Patel Paras, Gupta Sunita, Patel Happy, Bashar Md Abu
Department of General Medicine, MM Institute of Medical Sciences and Research, Ambala, Haryana, India.
Department of Obstetrics and Gynaecology, Shri Vinova Bhave Civil Hospital, Silvaasa, Dadar and Nagar Haveli, India.
Indian J Crit Care Med. 2022 Mar;26(3):276-281. doi: 10.5005/jp-journals-10071-24142.
The acute physiology and chronic health evaluation (APACHE) II severity score has shown a good calibration and discriminatory value across a range of disease processes and remains the most widely used source of prognostic information on the risk for death in patients admitted to intensive care units (ICUs).
To study APACHE II scores in patients of acute kidney injury (AKI) admitted in the ICU and to find its association with outcome.
One hundred patients with AKI aged 18 years or above were admitted in the ICU, department of general medicine, of a tertiary care institute in Haryana, North India, from October 2019 to September 2020, were studied. Patients who had known causes of chronic kidney disease (CKD), on maintenance hemodialysis, and those who underwent renal replacement therapy (RRT) or nephrectomy were excluded. All required investigations were performed, and data were collected. The patients were followed till discharge or in-hospital mortality.
The mean age of the patients was 55.92 ± 18.18 years. Male-female ratio was 1.5:1. Thirty-five percent of the admitted patients had an in-hospital mortality. Sepsis (47%) was the most common cause of AKI, and 83% of the patients had underlying comorbid conditions. The mean APACHE II score of the expired patients on admission, i.e., 24.80 ± 13.65, was found to be significantly higher compared to the mean APACHE II score (17.25 ± 10.12) of the discharged patients (-value <0.001). APACHE II score was found to have 57.14% sensitivity, 86.15% specificity, 69% PPV, 78.9% NPV, and 76% diagnostic accuracy to predict mortality among the AKI patients.
APACHE II scoring system has a good discrimination and calibration when applied to ICU-admitted AKI patients and is a good predictor of prognosis in them.
Patel P, Gupta S, Patel H, Bashar MDA. Assessment of APACHE II Score to Predict ICU Outcomes of Patients with AKI: A Single-center Experience from Haryana, North India. Indian J Crit Care Med 2022;26(3):276-281.
急性生理与慢性健康状况评价(APACHE)II严重程度评分在一系列疾病过程中均显示出良好的校准和鉴别价值,并且仍然是重症监护病房(ICU)收治患者死亡风险预后信息最广泛使用的来源。
研究入住ICU的急性肾损伤(AKI)患者的APACHE II评分,并找出其与预后的关联。
对2019年10月至2020年9月期间印度北部哈里亚纳邦一家三级医疗机构普通内科ICU收治的100例年龄在18岁及以上的AKI患者进行研究。排除已知患有慢性肾脏病(CKD)、正在接受维持性血液透析的患者,以及接受过肾脏替代治疗(RRT)或肾切除术的患者。进行了所有必要的检查并收集了数据。对患者进行随访直至出院或院内死亡。
患者的平均年龄为55.92±18.18岁。男女比例为1.5:1。35%的入院患者发生院内死亡。脓毒症(47%)是AKI最常见的病因,83%的患者有基础合并症。发现死亡患者入院时的平均APACHE II评分为24.80±13.65,显著高于出院患者的平均APACHE II评分(17.25±10.12)(P值<0.001)。发现APACHE II评分在预测AKI患者死亡率方面具有57.14%的敏感性、86.15%的特异性、69%的阳性预测值、78.9%的阴性预测值和76%的诊断准确性。
APACHE II评分系统应用于入住ICU的AKI患者时具有良好的鉴别和校准能力,是这些患者预后的良好预测指标。
帕特尔P,古普塔S,帕特尔H,巴沙尔MDA。评估APACHE II评分以预测AKI患者的ICU结局:来自印度北部哈里亚纳邦的单中心经验。《印度重症监护医学杂志》2022;26(3):27-281。